AlMoosa E, Al Ghadeer H, Alatiya J, Aldairam W, Alhamrani A, Alarbash A
Cureus. 2025; 16(12):e76272.
PMID: 39845243
PMC: 11753791.
DOI: 10.7759/cureus.76272.
Diabetes Care. 2024; 48(Supplement_1):S59-S85.
PMID: 39651988
PMC: 11635044.
DOI: 10.2337/dc25-S004.
Diabetes Care. 2024; 48(Supplement_1):S283-S305.
PMID: 39651980
PMC: 11635046.
DOI: 10.2337/dc25-S014.
Abugharbyeh A, Khuder S, Kahaleh B
J Scleroderma Relat Disord. 2024; :23971983241301231.
PMID: 39634481
PMC: 11613151.
DOI: 10.1177/23971983241301231.
Zhang Y, Fu L
Front Endocrinol (Lausanne). 2024; 15:1420499.
PMID: 39568808
PMC: 11576183.
DOI: 10.3389/fendo.2024.1420499.
B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases.
Wang Q, Feng D, Jia S, Lu Q, Zhao M
Clin Rev Allergy Immunol. 2024; 66(1):76-98.
PMID: 38459209
DOI: 10.1007/s12016-024-08984-6.
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2024.
Diabetes Care. 2023; 47(Suppl 1):S52-S76.
PMID: 38078591
PMC: 10725809.
DOI: 10.2337/dc24-S004.
14. Children and Adolescents: Standards of Care in Diabetes-2024.
Diabetes Care. 2023; 47(Suppl 1):S258-S281.
PMID: 38078582
PMC: 10725814.
DOI: 10.2337/dc24-S014.
Autoimmune primary adrenal insufficiency -current diagnostic approaches and future perspectives.
Wolff A, Kucuka I, Oftedal B
Front Endocrinol (Lausanne). 2023; 14:1285901.
PMID: 38027140
PMC: 10667925.
DOI: 10.3389/fendo.2023.1285901.
Important denominator between autoimmune comorbidities: a review of class II HLA, autoimmune disease, and the gut.
Berryman M, Ilonen J, Triplett E, Ludvigsson J
Front Immunol. 2023; 14:1270488.
PMID: 37828987
PMC: 10566625.
DOI: 10.3389/fimmu.2023.1270488.
Autoimmune diseases and their prevalence in Saudi Arabian patients with type 1 diabetes mellitus.
Mohammedsaeed W, Alghamdi Z
Saudi Med J. 2023; 44(8):751-760.
PMID: 37582563
PMC: 10425616.
DOI: 10.15537/smj.2023.44.8.20230240.
Accuracy of Serological Screening for the Diagnosis of Celiac Disease in Type 1 Diabetes Children.
Girard C, De Percin A, Morin C, Talvard M, Fortenfant F, Congy-Jolivet N
Medicina (Kaunas). 2023; 59(7).
PMID: 37512132
PMC: 10386403.
DOI: 10.3390/medicina59071321.
Islet transplantation-immunological challenges and current perspectives.
Kabakchieva P, Assyov Y, Gerasoudis S, Vasilev G, Peshevska-Sekulovska M, Sekulovski M
World J Transplant. 2023; 13(4):107-121.
PMID: 37388389
PMC: 10303418.
DOI: 10.5500/wjt.v13.i4.107.
Prevalence of Organ-Specific Autoimmunity in Patients With Type 1 Diabetes Mellitus.
Alam A, Singh S, Kumar R
Cureus. 2023; 15(5):e38855.
PMID: 37303388
PMC: 10256565.
DOI: 10.7759/cureus.38855.
[Diagnosis and insulin therapy of type 1 diabetes mellitus (Update 2023)].
Lechleitner M, Kaser S, Hoppichler F, Roden M, Weitgasser R, Ludvik B
Wien Klin Wochenschr. 2023; 135(Suppl 1):98-105.
PMID: 37101030
PMC: 10133075.
DOI: 10.1007/s00508-023-02182-8.
Effective assay technologies fit for large-scale population screening of type 1 diabetes.
Jia X, Yu L
Front Clin Diabetes Healthc. 2023; 3:1034698.
PMID: 36992730
PMC: 10012058.
DOI: 10.3389/fcdhc.2022.1034698.
Graves disease is more prevalent than Hashimoto disease in children and adolescents with type 1 diabetes.
Wang L, Huang C, Lin C, Cheng B, Lo F, Ting W
Front Endocrinol (Lausanne). 2023; 13:1083690.
PMID: 36704033
PMC: 9871454.
DOI: 10.3389/fendo.2022.1083690.
4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes-2023.
ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D
Diabetes Care. 2022; 46(Suppl 1):S49-S67.
PMID: 36507651
PMC: 9810472.
DOI: 10.2337/dc23-S004.
14. Children and Adolescents: Standards of Care in Diabetes-2023.
ElSayed N, Aleppo G, Aroda V, Bannuru R, Brown F, Bruemmer D
Diabetes Care. 2022; 46(Suppl 1):S230-S253.
PMID: 36507640
PMC: 9810473.
DOI: 10.2337/dc23-S014.
Shared etiology of type 1 diabetes and Hashimoto's thyroiditis: a population-based twin study.
Skov J, Kuja-Halkola R, Magnusson P, Gudbjornsdottir S, Kampe O, Bensing S
Eur J Endocrinol. 2022; 186(6):677-685.
PMID: 36321757
PMC: 9175555.
DOI: 10.1530/EJE-22-0025.